跳至主要内容
临床试验/NCT01470118
NCT01470118已完成4 期

A Study to Evaluate the Duration of LASTACAFT® in Acute Allergic Conjunctivitis

Allergan0 个研究点目标入组 127 人开始时间: 2011年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
Allergan
入组人数
127
主要终点
Ocular Itching Evaluated by the Subject at 3, 5, and 7 Minutes Post Challenge on Day 0 at Hour 16

研究概览

简要总结

This study will evaluate the duration of action of LASTACAFT® and Pataday™ as compared to artificial tears (placebo) in the prevention of ocular itching associated with allergic conjunctivitis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
10 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • History of eye allergies within the past 24 months
  • Willing to not wear contact lenses at least 72 hours prior to the study start and during the study period

排除标准

  • Current eye infection
  • Eye surgery within 3 months or vision correction surgery within 6 months
  • Any planned surgery during the study or 30 days after the study

研究组 & 干预措施

LASTACAFT® (alcaftadine 0.25%)

Active Comparator

One drop of alcaftadine 0.25% ophthalmic solution instilled in each eye at Day 0 and Day 14.

干预措施: alcaftadine 0.25% ophthalmic solution (Drug)

Pataday™ (olopatadine 0.2%)

Active Comparator

One drop of olopatadine 0.2% ophthalmic solution instilled in each eye at Day 0 and Day 14.

干预措施: olopatadine 0.2% ophthalmic solution (Drug)

Placebo (dextran 70 0.1%/hydroxypropyl methylcellulose 0.3%)

Placebo Comparator

One drop of placebo instilled in each eye at Day 0 and Day 14.

干预措施: dextran 70 0.1%/hydroxypropyl methylcellulose 0.3% (Drug)

结局指标

主要结局

Ocular Itching Evaluated by the Subject at 3, 5, and 7 Minutes Post Challenge on Day 0 at Hour 16

时间窗: Day 0 Hour 16

Ocular itching evaluated by the subject at 3, 5, and 7 minutes post challenge on Day 0 (Visit 3) at hour 16. Subjects scored their ocular itching on a numeric analog scale ranging from 0=None to 4=Incapacitating Itch with an Irresistible Urge to Rub (0.5 increments were allowed). For each subject, the score for both eyes was averaged (i.e., one score per subject). A lower score was indicative of less itching.

Ocular Itching Evaluated by the Subject at 3, 5, and 7 Minutes Post Challenge on Day 14 at Hour 24

时间窗: Day 14 Hour 24

Ocular itching evaluated by the subject at 3, 5, and 7 minutes post challenge on Day 14 (Visit 4) at hour 24. Subjects scored their ocular itching on a numeric analog scale ranging from 0=None to 4=Incapacitating Itch with an Irresistible Urge to Rub (0.5 increments were allowed). For each subject, the score for both eyes was averaged (i.e., one score per subject). A lower score was indicative of less itching.

次要结局

  • Conjunctival Redness Evaluated by the Investigator at 7, 15, and 20 Minutes Post Challenge on Day 14 at Hour 24(Day 14 Hour 24)
  • Ciliary Redness Evaluated by the Investigator at 7, 15, and 20 Minutes Post Challenge on Day 14 at Hour 24(Day 14 Hour 24)
  • Episcleral Redness Evaluated by the Investigator at 7, 15, and 20 Minutes Post Challenge on Day 14 at Hour 24(Day 14 Hour 24)
  • Chemosis Evaluated by the Investigator at 7, 15, and 20 Minutes Post Challenge on Day 14 at Hour 24(Day 14 Hour 24)
  • Eyelid Swelling Evaluated by the Subject at 7, 15, and 20 Minutes Post Challenge on Day 14 at Hour 24(Day 14 Hour 24)
  • Tearing Evaluated by the Subject at 7, 15, and 20 Minutes Post Challenge on Day 14 at Hour 24(Day 14 Hour 24)

研究者

发起方
Allergan
申办方类型
Industry
责任方
Sponsor

相似试验